|
KCTD10 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.95329999952421E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.19519999997042E-06 |
| Normal-vs-Stage2 |
1.91069999999627E-06 |
| Normal-vs-Stage3 |
6.13409999999925E-05 |
| Normal-vs-Stage4 |
1.436380E-03 |
| Stage1-vs-Stage2 |
4.808600E-01 |
| Stage1-vs-Stage3 |
7.322800E-01 |
| Stage1-vs-Stage4 |
8.147600E-01 |
| Stage2-vs-Stage3 |
3.850000E-01 |
| Stage2-vs-Stage4 |
8.855600E-01 |
| Stage3-vs-Stage4 |
6.463400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.14819999952331E-07 |
| Normal-vs-AfricanAmerican |
4.777300E-04 |
| Normal-vs-Asian |
4.561400E-03 |
| Caucasian-vs-AfricanAmerican |
1.147610E-01 |
| Caucasian-vs-Asian |
8.897600E-01 |
| AfricanAmerican-vs-Asian |
5.053200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.93859997130875E-09 |
| Normal-vs-Female |
1.136720E-03 |
| Male-vs-Female |
2.208300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.222860E-04 |
| Normal-vs-Extreme_Weight |
1.20330000408231E-08 |
| Normal-vs-Obese |
1.56814999999755E-05 |
| Normal-vs-Extreme_Obese |
2.35879999999078E-06 |
| Normal_Weight-vs-Extreme_Weight |
2.655400E-01 |
| Normal_Weight-vs-Obese |
8.627600E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.230400E-02 |
| Extreme_Weight-vs-Obese |
1.050410E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.402000E-01 |
| Obese-vs-Extreme_Obese |
6.934100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.543700E-03 |
| Normal-vs-Age(41-60Yrs) |
8.37670000000124E-05 |
| Normal-vs-Age(61-80Yrs) |
1.62669999692611E-08 |
| Normal-vs-Age(81-100Yrs) |
1.998890E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.776600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.400410E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.384620E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.000200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.315400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.149200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.66250000011826E-08 |
| Normal-VS-Type2 PRCC |
3.12760000009682E-07 |
| Normal-VS-KIRP CIMP |
5.177500E-03 |
| Normal-VS-Unclassified PRCC |
5.121200E-03 |
| Type1 PRCC-VS-Type2 PRCC |
4.183000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
6.636200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.875200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.567200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.225010E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
7.929800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.10510001150033E-09 |
| Normal-vs-N1 |
1.256270E-03 |
| Normal-vs-N2 |
3.785600E-02 |
| N0-vs-N1 |
6.637900E-02 |
| N0-vs-N2 |
4.120800E-01 |
| N1-vs-N2 |
8.975400E-01 |
|
|
